FDA approves Qlosi for treatment of presbyopia in adults

The U.S. Food and Drug Administration has approved Qlosi (pilocarpine hydrochloride ophthalmic solution; Orasis Pharmaceuticals) 0.4% for the treatment of presbyopia in adults. QLOSI is expected to be commercially available in the U.S. in the first half of 2024. Qlosi is a prescription eye drop that can be used daily, or...